Weight loss and malnutrition in patients with chronic graft-versus-host disease

被引:49
|
作者
Jacobsohn, DA [1 ]
Margolis, J [1 ]
Doherty, J [1 ]
Anders, V [1 ]
Vogelsang, GB [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
关键词
chronic graft-versus-host disease; weight loss; malnutrition; hematopoietic stem cell transplantation;
D O I
10.1038/sj.bmt.1703352
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
It is well known that weight loss occurs in patients with chronic graft-versus-host disease. However, the severity and frequency of weight loss in this population have not been adequately described. Recent data suggest that a body-mass index (BMI) below 21.9 is an independent risk factor for mortality. In our analysis we have shown that out of 93 patients with cGVHD, 43% are malnourished as evidenced by a BMI less than 21.9 and 14% are severely malnourished (BMI less than 18.5). In addition, there is a clear trend showing that patients with active, ongoing cGVHD have lower BMIs (P = 0.02). Furthermore, we show that many symptoms thought to contribute to weight loss in patients with cGVHD, such as odynophagia and oral sensitivity, are not related to weight loss in our population. We conclude that, in all likelihood, unknown causes still exist that are responsible for weight loss in this group of patients. Elevated resting energy expenditure and elevated serum tumor necrosis factor-a are potential contributors to weight loss that will be tested in future studies. We also conclude that treating cGVHD aggressively may help reverse weight loss and malnutrition, which may be independent risk factors for mortality in this population.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 50 条
  • [31] The Treatment of Chronic Graft-Versus-Host Disease
    Wolff, Daniel
    Bertz, Hartmut
    Greinix, Hildegard
    Lawitschka, Anita
    Halter, Joerg
    Holler, Ernst
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (43): : 732 - I
  • [32] Development of chronic graft-versus-host disease
    Slayback, DL
    Dobkins, JA
    Harper, JM
    Allen, RD
    FASEB JOURNAL, 2000, 14 (06): : A1074 - A1074
  • [33] TO BE, OR NOT TO BE CHRONIC GRAFT-VERSUS-HOST DISEASE, THAT IS THE QUESTION
    Juarez-Vignon Whaley, J.
    Carrillo-Martin, I.
    Incontri-Abraham, D.
    Gonzalez-Estrada, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S85 - S86
  • [34] Chronic cutaneous graft-versus-host disease
    Liu Ye-qiang
    Xiong Xiao-gang
    JOURNAL OF DERMATOLOGY, 2012, 39 : 262 - 263
  • [35] Updates in chronic graft-versus-host disease
    Hamilton, Betty K.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 648 - 654
  • [36] ROCKing Chronic Graft-Versus-Host Disease
    Heine, Annkristin
    Holderried, Tobias A. W.
    Wolf, Dominik
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (29)
  • [37] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212
  • [38] Chronic polyarthritis and graft-versus-host disease
    NaranjoHernandez, A
    Mataix, R
    RodriguezLozano, C
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (03): : 297 - 298
  • [39] Re: Chronic graft-versus-host disease
    Flowers, MED
    Lee, S
    Vogelsang, G
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (08) : 540 - 540
  • [40] THE MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    SIADAK, M
    SULLIVAN, KM
    BLOOD REVIEWS, 1994, 8 (03) : 154 - 160